Pharmaceuticals, Biotechnology and Life Sciences
Complete radiologic responses linked to T cell activity observed in two of first six evaluable patients IMV to host investor…
The Company Expects to Initiate a Phase 2 Trial in Patients with Schizophrenia in the Fourth Quarter of 2019 LEXINGTON,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced that management will host…
DUBLIN–(BUSINESS WIRE)–The “Global Cervical Dysplasia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Cervical Dysplasia…
DUBLIN–(BUSINESS WIRE)–The “Global Pompe’s Disease Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Pompe’s Disease…
DUBLIN–(BUSINESS WIRE)–The “Global Idiopathic Thrombocytopenic Purpura Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Idiopathic…
DUBLIN–(BUSINESS WIRE)–The “Global T-Cell Leukemia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. T-Cell Leukemia…
DUBLIN–(BUSINESS WIRE)–The “Global Fabry Disease Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Fabry Disease…
DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Chronic Pain…
DUBLIN–(BUSINESS WIRE)–The “Global HIV Treatment Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. HIV Treatment…